What is ZetaGen Therapeutics worth?
$180.0Mlast known valuation
ZetaGen Therapeutics last raised $12.9M in its Early Stage VC (Jan 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for ZetaGen Therapeutics
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2025 | Early Stage VC | $12.9M | ▮ | ▮ |
| Apr 2022 | Early Stage VC | $9.6M | ▮ | ▮ |
| Dec 2019 | Seed Round | $840K | ▮ | ▮ |
| Jul 2018 | Debt | $1.0M | ▮ | ▮ |
How ZetaGen Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For ZetaGen Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is ZetaGen Therapeutics worth?
- ZetaGen Therapeutics's last known valuation is $180.0M.
- How much has ZetaGen Therapeutics raised?
- ZetaGen Therapeutics has raised $52.5M in total funding across 4 recorded rounds.
- When did ZetaGen Therapeutics last raise?
- ZetaGen Therapeutics last raised in Jan 2025 (Early Stage VC), raising $12.9M.